AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20436241 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 122
Study 18461096 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (1 g x kg body mass(‐1))
Number of subjects: 11
Study 18461096 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CON)
Number of subjects: 11
Study 17142257 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination of care home staff in intervention homes (n=1703)
Number of subjects: 2604
Study 17142257 — intervention group
Group type: COMPARATOR
Intervention: No vaccination of care home staff in control homes (n=1703)
Number of subjects: 2604
Study 12679283 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year, home- and clinic-based intervention
Number of subjects: 30
Study 12679283 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control condition
Number of subjects: 30
Study 10735538 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg bolus followed by 8 or 4 mg/h infusion)
Number of subjects: 629
Study 10735538 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (800 mg/12 h)
Number of subjects: 629
Study 9411335 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg betaxolol monotherapy
Number of subjects: 21
Study 1388092 — intervention group
Group type: EXPERIMENTAL
Intervention: etodolac 600 mg/day
Number of subjects: 116
Study 1388092 — intervention group
Group type: COMPARATOR
Intervention: piroxicam 20 mg/day
Number of subjects: 116
Study 2859877 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam 1.5-3 mg/day
Number of subjects: 0
Study 2859877 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 15-30 mg/day
Number of subjects: 0
Study 2859877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28852985 — intervention group
Group type: EXPERIMENTAL
Intervention: Multistrain Lactobacillus brevis (one vaginal capsule every 12 hours)
Number of subjects: 81
Study 28852985 — intervention group
Group type: COMPARATOR
Intervention: Acyclovir (400 mg orally twice daily)
Number of subjects: 81
Study 28852985 — intervention group
Group type: EXPERIMENTAL
Intervention: Multistrain Lactobacillus brevis
Number of subjects: 81
Study 28852985 — intervention group
Group type: COMPARATOR
Intervention: Acyclovir
Number of subjects: 81
Study 28492612 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stent (DES) therapy (Relieva StratusTM MicroFlow Spacer)
Number of subjects: 63
Study 28492612 — intervention group
Group type: COMPARATOR
Intervention: Topical intranasal corticosteroid therapy (nasal spray)
Number of subjects: 63
Study 26432775 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial pancreas (AP) use from dinner to waking up plus sensor-augmented pump therapy (SAP) during the day
Number of subjects: 0
Study 26432775 — intervention group
Group type: COMPARATOR
Intervention: Sensor-augmented pump therapy (SAP) only
Number of subjects: 0
Study 26432775 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial pancreas (AP) use
Number of subjects: 0
Study 24490236 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue-centered treatment
Number of subjects: 65
Study 24490236 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 65
Study 21434995 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide once-weekly
Number of subjects: 364
Study 21434995 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin to exenatide once-weekly
Number of subjects: 364
Study 21434995 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone to exenatide once-weekly
Number of subjects: 364
Study 18821092 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg
Number of subjects: 0
Study 18821092 — intervention group
Group type: COMPARATOR
Intervention: Estradiol 2 mg
Number of subjects: 0
Study 18821092 — intervention group
Group type: COMPARATOR
Intervention: Estradiol 2 mg + NETA 1 mg
Number of subjects: 0
Study 18821092 — intervention group
Group type: COMPARATOR
Intervention: Tibolone 2.5 mg
Number of subjects: 0
Study 16880021 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior group intervention
Number of subjects: 104
Study 16880021 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study 12499331 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich breakfast (69.9 g carbohydrate and 5.2 g protein)
Number of subjects: 9
Study 12499331 — intervention group
Group type: COMPARATOR
Intervention: Protein-rich breakfast (15.4 g carbohydrate and 46.8 g protein)
Number of subjects: 9
Study 10462247 — intervention group
Group type: EXPERIMENTAL
Intervention: S. sonnei-rEPA
Number of subjects: 0
Study 10462247 — intervention group
Group type: EXPERIMENTAL
Intervention: S. flexneri 2a-rEPA
Number of subjects: 0
Study 10462247 — intervention group
Group type: COMPARATOR
Intervention: Pre-vaccination
Number of subjects: 0
Study 10462247 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 0
Study 8927665 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic disorder patients post-drug trial follow-up
Number of subjects: 423
Study 8927665 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline disability measures
Number of subjects: 423
Study 8927665 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic attack frequency and phobic avoidance at baseline
Number of subjects: 423
Study 1842158 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.2% lidocaine hydrocarbonate
Number of subjects: 30
Study 1842158 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.2% lidocaine hydrocarbonate with 1:100,000 epinephrine
Number of subjects: 30
Study 1842158 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine hydrochloride with 1:100,000 epinephrine
Number of subjects: 30
Study 1842158 — intervention group
Group type: COMPARATOR
Intervention: Control (contralateral canine)
Number of subjects: 30
Study 6688450 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 alpha‐hydroxy‐derivatives of vitamin D
Number of subjects: 22
Study 31351084 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium silicate + sodium phosphate
Number of subjects: 10
Study 31351084 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium nitrate
Number of subjects: 10
Study 31351084 — intervention group
Group type: COMPARATOR
Intervention: Regular fluoridated toothpaste
Number of subjects: 10
Study 31351084 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensitizing toothpastes (arginine + calcium carbonate, calcium sodium phosphosilicate, strontium acetate, stannous fluoride)
Number of subjects: 10
Study 31351084 — intervention group
Group type: COMPARATOR
Intervention: Human saliva
Number of subjects: 10
Study 31351084 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligopeptide-104
Number of subjects: 10
Study 31351084 — intervention group
Group type: EXPERIMENTAL
Intervention: Stannous chloride + chitosan
Number of subjects: 10
Study 29949045 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab 100 mg subcutaneous (SC)
Number of subjects: 0
Study 29949045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29949045 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab 100 mg SC
Number of subjects: 0
Study 27623621 — intervention group
Group type: COMPARATOR
Intervention: Nimodipine alone (30 mg/time, 3 times daily)
Number of subjects: 126
Study 27623621 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture alone (30 min/time, 6 times/week)
Number of subjects: 126
Study 27623621 — intervention group
Group type: COMPARATOR
Intervention: Nimodipine + Acupuncture
Number of subjects: 126
Study 27623621 — intervention group
Group type: COMPARATOR
Intervention: Nimodipine alone
Number of subjects: 126
Study 27623621 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture alone
Number of subjects: 126
Study 24990088 — intervention group
Group type: EXPERIMENTAL
Intervention: Active drug treatment
Number of subjects: 160
Study 24990088 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 160
Study 22633824 — intervention group
Group type: EXPERIMENTAL
Intervention: REGN727 150 mg every 4 weeks
Number of subjects: 77
Study 22633824 — intervention group
Group type: EXPERIMENTAL
Intervention: REGN727 200 mg every 4 weeks
Number of subjects: 77
Study 22633824 — intervention group
Group type: EXPERIMENTAL
Intervention: REGN727 300 mg every 4 weeks
Number of subjects: 77
Study 22633824 — intervention group
Group type: EXPERIMENTAL
Intervention: REGN727 150 mg every 2 weeks
Number of subjects: 77
Study 22633824 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 20673785 — intervention group
Group type: EXPERIMENTAL
Intervention: Pronamel toothpaste applied after demineralization with soft drink
Number of subjects: 50
Study 20673785 — intervention group
Group type: EXPERIMENTAL
Intervention: Biorepair Plus toothpaste applied after demineralization with soft drink
Number of subjects: 50
Study 20673785 — intervention group
Group type: EXPERIMENTAL
Intervention: Pronamel toothpaste applied to intact enamel
Number of subjects: 50
Study 20673785 — intervention group
Group type: EXPERIMENTAL
Intervention: Biorepair Plus toothpaste applied to intact enamel
Number of subjects: 50
Study 20673785 — intervention group
Group type: COMPARATOR
Intervention: Demineralization with soft drink (control group)
Number of subjects: 50
Study 17120016 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day post-loading maintenance diet of 60% carbohydrate
Number of subjects: 17
Study 17120016 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day post-loading maintenance diet of 60% carbohydrate
Number of subjects: 17
Study 17120016 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day post-loading maintenance diet of 60% carbohydrate
Number of subjects: 17
Study 15866433 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion-weighted magnetic resonance imaging
Number of subjects: 21
Study 15866433 — intervention group
Group type: COMPARATOR
Intervention: Conventional and diffusion-weighted magnetic resonance imaging
Number of subjects: 21
Study 12370680 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 50
Study 12370680 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 50
Study 11572048 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 15
Study 11572048 — intervention group
Group type: COMPARATOR
Intervention: Alternative vegetable oils
Number of subjects: 15
Study 9237054 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC)
Number of subjects: 287
Study 9237054 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin (PHT)
Number of subjects: 287
Study 7679269 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon green laser
Number of subjects: 210
Study 7679269 — intervention group
Group type: COMPARATOR
Intervention: Krypton red laser
Number of subjects: 210
Study 3548345 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid regimen (a mixture of regular and Lente insulins twice daily)
Number of subjects: 43
Study 3548345 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen (Lente insulin once daily)
Number of subjects: 43
Study 3548345 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid/intravenous regimen (the 'rapid' regimen preceded by overnight intravenous infusion of regular insulin)
Number of subjects: 43
Study 29087093 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.147% ethyl lauroyl arginate (LAE) mouthwash
Number of subjects: 40
Study 29087093 — intervention group
Group type: COMPARATOR
Intervention: 0.12% chlorhexidine (CHX) mouthwash
Number of subjects: 40
Study 27618461 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual peer support from a trained peer specialist
Number of subjects: 113
Study 27618461 — intervention group
Group type: COMPARATOR
Intervention: Control group (other supportive, peer-delivered services excluding individual peer support)
Number of subjects: 113
Study 24628492 — intervention group
Group type: EXPERIMENTAL
Intervention: Resource ThickenUp Clear (xanthan gum-based thickener)
Number of subjects: 120
Study 23519697 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel exercise 2-3 times per week
Number of subjects: 25
Study 23519697 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 25
Study 20399023 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 200
Study 20399023 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 200
Study 20399023 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom use
Number of subjects: 200
Study 18422390 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin extended release and simvastatin (NER/S) 2,000/40 mg/day
Number of subjects: 520
Study 16052221 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral prophylactic mastectomy (CPM)
Number of subjects: 148
Study 16052221 — intervention group
Group type: COMPARATOR
Intervention: Surveillance
Number of subjects: 148
Study 14578234 — intervention group
Group type: COMPARATOR
Intervention: Normal Glucose Tolerance (NGT)
Number of subjects: 595
Study 14578234 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired Glucose Tolerance (IGT)
Number of subjects: 595
Study 14578234 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline factors associated with worsening glucose tolerance
Number of subjects: 595
Study 14578234 — intervention group
Group type: EXPERIMENTAL
Intervention: IGT reverting to NGT
Number of subjects: 595
Study 14578234 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum triglyceride, HDL cholesterol, and insulin resistance values in 2000
Number of subjects: 595
Study 14578234 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD risk factors associated with IGT
Number of subjects: 595
Study 10579264 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 30
Study 10579264 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 30
Study 10579264 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30
Study 8920701 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-Hep-B (2.5 micrograms)
Number of subjects: 217
Study 8920701 — intervention group
Group type: COMPARATOR
Intervention: Engerix-B (10 micrograms)
Number of subjects: 217
Study 1986529 — intervention group
Group type: EXPERIMENTAL
Intervention: Counterrotational power toothbrush
Number of subjects: 20
Study 1986529 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 20
Study 29662130 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention in intervention communities (n=12)
Number of subjects: 200
Study 29662130 — intervention group
Group type: COMPARATOR
Intervention: Usual care in control communities (n=12)
Number of subjects: 200
Study 29855986 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract EGb 761, 120 mg twice a day
Number of subjects: 197
Study 29855986 — intervention group
Group type: COMPARATOR
Intervention: Pentoxifylline, 600 mg twice a day
Number of subjects: 197
Study 26892690 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic radiofrequency volumetric thermal ablation (RFVTA)
Number of subjects: 51
Study 26892690 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic myomectomy
Number of subjects: 51
Study 24908429 — intervention group
Group type: EXPERIMENTAL
Intervention: Early and intensive nutrition intervention (NI) delivered over the telephone/face‐to‐face
Number of subjects: 21
Study 24908429 — intervention group
Group type: EXPERIMENTAL
Intervention: Early and intensive nutrition intervention (NI)
Number of subjects: 21
Study 24908429 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition care (SC)
Number of subjects: 21
Study 22369095 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 16
Study 22369095 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine
Number of subjects: 16
Study 18285398 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine 100 microg/kg/min
Number of subjects: 14
Study 18285398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 17760655 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg once daily
Number of subjects: 254
Study 17760655 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 150 mg twice daily
Number of subjects: 254
Study 17760655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 16398426 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional herbal medicine (CM) therapy
Number of subjects: 413
Study 16398426 — intervention group
Group type: COMPARATOR
Intervention: Western medicine (WM) therapy
Number of subjects: 413
Study 12173961 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage using The Stick
Number of subjects: 30
Study 12173961 — intervention group
Group type: COMPARATOR
Intervention: Visualization (control)
Number of subjects: 30
Study 12173961 — intervention group
Group type: COMPARATOR
Intervention: Mock insensible electrical stimulation (placebo)
Number of subjects: 30
Study 9690725 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg o.m. for 4-8 weeks
Number of subjects: 98
Study 9690725 — intervention group
Group type: COMPARATOR
Intervention: Sucralfate 2 g b.d. for 4-8 weeks
Number of subjects: 98
Study 8594677 — intervention group
Group type: EXPERIMENTAL
Intervention: Maloprim (pyrimethamine plus dapsone)
Number of subjects: 0
Study 8594677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2564901 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated patients with newly diagnosed prostate cancer
Number of subjects: 223
Study 2564901 — intervention group
Group type: COMPARATOR
Intervention: Poorly differentiated tumours
Number of subjects: 223
Study 581421 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibacterial preparation with phthalylsulfathiazole and neomycin
Number of subjects: 290
Study 581421 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibacterial preparation with phthalylsulfathiazole, neomycin, and tetracycline
Number of subjects: 290
Study 581421 — intervention group
Group type: COMPARATOR
Intervention: No antibacterial preparation
Number of subjects: 290
Study 31922333 — intervention group
Group type: EXPERIMENTAL
Intervention: RARC
Number of subjects: 298
Study 31922333 — intervention group
Group type: COMPARATOR
Intervention: LRC
Number of subjects: 298
Study 31432438 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOICE care management intervention
Number of subjects: 304
Study 31432438 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 304
Study 28765494 — intervention group
Group type: EXPERIMENTAL
Intervention: EPAP with 10 cm H2O (EPAP10)
Number of subjects: 15
Study 28765494 — intervention group
Group type: EXPERIMENTAL
Intervention: EPAP with 5 cm H2O (EPAP5)
Number of subjects: 15
Study 28765494 — intervention group
Group type: COMPARATOR
Intervention: No EPAP
Number of subjects: 15
Study 25873295 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-Body Bridging (MBB)
Number of subjects: 30
Study 25873295 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation (MM)
Number of subjects: 30
Study 25873295 — intervention group
Group type: COMPARATOR
Intervention: Sleep Hygiene Education (SHE)
Number of subjects: 30
Study 24039409 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral supplementation with omega-3 fatty acids (1.5 grams per day)
Number of subjects: 61
Study 24039409 — intervention group
Group type: COMPARATOR
Intervention: Placebo oral agent
Number of subjects: 61
Study 20572888 — intervention group
Group type: EXPERIMENTAL
Intervention: Urea 2% cream (GEHWOL FUSSKRAFT blau)
Number of subjects: 0
Study 20572888 — intervention group
Group type: EXPERIMENTAL
Intervention: Petrolatum containing cream (GEHWOL med Schrundensalbe)
Number of subjects: 0
Study 20572888 — intervention group
Group type: EXPERIMENTAL
Intervention: Urea 10% cream (GEHWOL med Lipidro‐Crème)
Number of subjects: 0
Study 20572888 — intervention group
Group type: EXPERIMENTAL
Intervention: Urea 10% foam (Allpresan Fuss Schaum)
Number of subjects: 0
Study 20572888 — intervention group
Group type: COMPARATOR
Intervention: Vaseline (positive control)
Number of subjects: 0
Study 20572888 — intervention group
Group type: COMPARATOR
Intervention: Untreated area on the volar forearms
Number of subjects: 0
Study 19895185 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic asthma monitoring system (AMS)
Number of subjects: 59
Study 19895185 — intervention group
Group type: COMPARATOR
Intervention: Paper diary
Number of subjects: 59
Study 17122719 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical Prostatectomy (RP) recommendation for black patients with high social vulnerability
Number of subjects: 1313
Study 17122719 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical Prostatectomy (RP) recommendation for white patients with high social vulnerability
Number of subjects: 1313
Study 15583533 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide preoperatively for 20 minutes
Number of subjects: 36
Study 15583533 — intervention group
Group type: COMPARATOR
Intervention: 100% oxygen preoperatively for 20 minutes (control)
Number of subjects: 36
Study 15583533 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide postoperatively for 20 minutes
Number of subjects: 36
Study 15583533 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-point categorical patient global assessment scale
Number of subjects: 36
Study 11736884 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tropisetron (5 mg)
Number of subjects: 18
Study 11736884 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tropisetron (2 mg)
Number of subjects: 18
Study 9406126 — intervention group
Group type: EXPERIMENTAL
Intervention: GLN-enriched TPN (GT)
Number of subjects: 20
Study 9406126 — intervention group
Group type: COMPARATOR
Intervention: Standard TPN (ST)
Number of subjects: 20
Study 8503942 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 and vitamin B6 (pyridoxine) administered together
Number of subjects: 3
Study 8503942 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 administered alone
Number of subjects: 3
Study 8503942 — intervention group
Group type: COMPARATOR
Intervention: Vitamin B6 (pyridoxine) administered alone
Number of subjects: 3
Study 2449724 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral prostatectomy (TURP)
Number of subjects: 21
Study 2449724 — intervention group
Group type: COMPARATOR
Intervention: Transurethral incision of the prostate (TUI)
Number of subjects: 21